Table of Content - Global Geriatric Medicines Market

Global geriatric medicines market is estimated to be valued at USD 1,004.71 Bn in 2024 and is expected to reach USD 1,570.18 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031. Geriatric medicines refer to the medical products that are used for the treatment of age-related diseases and conditions among people of age 60 years and above. Growing geriatric population across the globe is considered a major driver for the market growth. As per WHO 2022 estimates, by 2050 around 22% of the world's population will be aged 60 years and above. With increased life expectancy and declining birth rates, the number of elderly citizens are increasing that leads to increasing prevalence of chronic and lifestyle conditions such as cardiovascular diseases, cancer, diabetes, and others, requiring long term medical care. With limited treatment options available currently, geriatric medicines provide targeted solutions to treat diseases commonly affecting the aged people. Developing efficient healthcare infrastructure and medical solutions specifically addressing needs of elderly citizens is the essential need for governments and medical device manufacturers across regions.

Market Dynamics:

Global geriatric medicines market is projected to witness moderate growth during the forecast period owing to several drivers such as rising geriatric population worldwide, increasing government initiatives to enhance healthcare for senior citizens, and growing prevalence of chronic diseases among the aged population. The rising pool of elderly will significantly boost demand for various categories of geriatric medicines in the near future. However, factors such as lower diagnosis and treatment rates for diseases among elderly in developing nations and stringent regulatory norms for approval of new drugs may impede the market growth. Meanwhile, development of innovative and generic drugs with minimal side-effects targeted to the requirements of aged remains an untapped opportunity for market players.

Key Features of the Study:

This report provides in-depth analysis of the global geriatric medicines market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global geriatric medicines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes Pfizer Inc., Takeda Pharmaceutical Company Limited, Janssen Pharmaceuticals, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Boehringer Ingelheim, Eli Lilly and Company, Bristol Myers Squibb, Daiichi Sankyo Company, Limited, Bausch Health Companies, Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals, Eisai Co., Ltd., Ferring Pharmaceuticals, UCB, Evoke Pharma, and Cadila Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global geriatric medicines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global geriatric medicines market

Detailed Segmentation-

Disease Indication:
- Oncology
- Orthopedic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Neurological Disorders
- Metabolic Disorders
- Others
Form:
- Tablet
- Liquid
- Capsule
- Inhalers
- Topical
- Others
Route of Administration:
- Oral
- Parenteral
  - Intravenous
  - Intramuscular
  - Subcutaneous
- Others
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- Janssen Pharmaceuticals
- Sun Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Boehringer Ingelheim
- Eli Lilly and Company
- Bristol Myers Squibb
- Daiichi Sankyo Company, Limited
- Bausch Health Companies
- Mallinckrodt Pharmaceuticals
- Endo Pharmaceuticals
- Eisai Co., Ltd.
- Ferring Pharmaceuticals
- UCB
- Evoke Pharma
- Cadila Pharmaceuticals

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Disease Indication
  - Market Snapshot, By Form
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
Global Geriatric Medicines Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
Global Geriatric Medicines Market, By Disease Indication, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- Oncology
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Orthopedic Disorders
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Cardiovascular Disorders
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Respiratory Disorders
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Neurological Disorders
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Metabolic Disorders
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Geriatric Medicines Market, By Form, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- Tablet
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Liquid
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Capsule
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Inhalers
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Topical
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Geriatric Medicines Market, By Route of Administration, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- Oral
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Parenteral
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    - Intravenous
    - Intramuscular
    - Subcutaneous
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Geriatric Medicines Market, By Distribution Channel, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- Hospital Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Retail Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Online Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Geriatric Medicines Market, By Region, 2019 – 2031, (USD Bn)
- Introduction
  - Market Share Analysis, By Region, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, For Region, 2020–2031
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Pfizer Inc.*
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Takeda Pharmaceutical Company Limited
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Janssen Pharmaceuticals
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Sun Pharmaceutical Industries Ltd.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - AbbVie Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Boehringer Ingelheim
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Eli Lilly and Company
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Bristol Myers Squibb
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Daiichi Sankyo Company, Limited
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Bausch Health Companies
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Mallinckrodt Pharmaceuticals
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Endo Pharmaceuticals
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Eisai Co., Ltd.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Ferring Pharmaceuticals
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - UCB
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Evoke Pharma
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Cadila Pharmaceuticals
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 34 market data tables and 36 figures on "Geriatric Medicines Market” -Global forecast to 2031

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount